<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-06-04 16:55:48Endocrine system G protein coupled receptors PEGylation Pharmacokinetics Vasoactive intestinal peptide Bronchoalveolar lavage Pituitary adenylate cyclase-activating peptide Roxithromycin Secretin family Biology Peptide hormones Chemistry |
Add to Reading List |
Chemical synthesis and formulation design of a PEGylated vasoactive intestinal peptide derivative with improved metabolic stability | ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra PrDocID: 1uHNe - View Document |
 | Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1DocID: 1rrGr - View Document |
 | Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1DocID: 1rrm1 - View Document |
 | Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document |
 | Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document |